{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:41Z","timestamp":1791404501609,"version":"4.3.3"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/T024607\/1"],"award-info":[{"award-number":["EP\/T024607\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"crossref","award":["NIF\\R1\\191571"],"award-info":[{"award-number":["NIF\\R1\\191571"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Every sixth person in the world dies due to cancer, making it the second leading severe cause of death after cardiovascular diseases. According to WHO, cancer claimed nearly 10 million deaths in 2020. The most common types of cancers reported have been breast (lung, colon and rectum, prostate cases), skin (non-melanoma) and stomach. In addition to surgery, the most widely used traditional types of anti-cancer treatment are radio- and chemotherapy. However, these do not distinguish between normal and malignant cells. Additional treatment methods have evolved over time for early detection and targeted therapy of cancer. However, each method has its limitations and the associated treatment costs are quite high with adverse effects on the quality of life of patients. Use of individual atoms or a cluster of atoms (nanoparticles) can cause a paradigm shift by virtue of providing point of sight sensing and diagnosis of cancer. Nanoparticles (1\u2013100\u00a0nm in size) are 1000 times smaller in size than the human cell and endowed with safer relocation capability to attack mechanically and chemically at a precise location which is one avenue that can be used to destroy cancer cells precisely. This review summarises the extant understanding and the work done in this area to pave the way for physicians to accelerate the use of hybrid mode of treatments by leveraging the use of various nanoparticles.<\/jats:p>","DOI":"10.1007\/s10555-023-10086-2","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T10:03:02Z","timestamp":1677232982000},"page":"601-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Nanoparticle-mediated cancer cell therapy: basic science to clinical applications"],"prefix":"10.1007","volume":"42","author":[{"given":"Jaya","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caaisha","family":"Warsame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar Kottayasamy","family":"Seenivasagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal Kumar","family":"Katiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman","family":"Aleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8694-332X","authenticated-orcid":false,"given":"Saurav","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"10086_CR1","doi-asserted-by":"crossref","unstructured":"Sung, H., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 71(3), 209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"10086_CR2","doi-asserted-by":"publisher","unstructured":"Castiglioni, A. (1947). A history of medicine. Book. https:\/\/doi.org\/10.4324\/9780429019883","DOI":"10.4324\/9780429019883"},{"issue":"1","key":"10086_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31\u201346.","journal-title":"Cancer Discovery"},{"key":"10086_CR4","unstructured":"Pedmedical. Healthy cell. 2022; Available from: https:\/\/www.shutterstock.com\/discover\/stock-assets-uk-0220?c3apidt=p11180842815&gclid=CjwKCAjwhNWZBhB_EiwAPzlhNkuEWQgNIi53MLZ7pPjOlHI2burmAnSGE3NyvROPpvHk2zrj9nG3cRoCxwUQAvD_BwE&gclsrc=aw.ds&kw=shutterstock."},{"key":"10086_CR5","unstructured":"Clinic, C. Carcinoma. 2019; Available from: https:\/\/my.clevelandclinic.org\/health\/diseases\/23180-carcinoma#:~:text=Carcinoma%20is%20cancer%20that%20forms,head%20and%20neck%20are%20carcinomas."},{"key":"10086_CR6","unstructured":"Selchick, F. Cancer: Types, causes, prevention, and more. 2022; Available from: https:\/\/www.healthline.com\/health\/cancer#:~:text=Types%20of%20cancer&text=Carcinoma%20is%20a%20cancer%20that,cancers%20of%20the%20immune%20system."},{"key":"10086_CR7","unstructured":"Institute, N.C. What Is Cancer? 2021; Available from: https:\/\/www.cancer.gov\/about-cancer\/understanding\/what-is-cancer#:~:text=Cancer%20is%20a%20disease%20caused,are%20also%20called%20genetic%20changes."},{"issue":"81","key":"10086_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/tl.8101","volume":"2000","author":"JL Cooper","year":"2000","unstructured":"Cooper, J. L., & Robinson, P. (2000). The argument for making large classes seem small. New Directions for Teaching and Learning, 2000(81), 5\u201316.","journal-title":"New Directions for Teaching and Learning"},{"key":"10086_CR9","doi-asserted-by":"publisher","unstructured":"Editorial. (2021). Advancing cancer therapy. Nature Cancer, 2(3), 245\u2013246. https:\/\/doi.org\/10.1038\/s43018-021-00192-x","DOI":"10.1038\/s43018-021-00192-x"},{"issue":"11","key":"10086_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain, R. K., & Stylianopoulos, T. (2010). Delivering nanomedicine to solid tumors. Nature Reviews Clinical Oncology, 7(11), 653\u2013664.","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"8","key":"10086_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2174\/138920009790274540","volume":"10","author":"JC-M Hu","year":"2009","unstructured":"Hu, J.C.-M., & Zhang, L. (2009). Therapeutic nanoparticles to combat cancer drug resistance. Current Drug Metabolism, 10(8), 836\u2013841.","journal-title":"Current Drug Metabolism"},{"issue":"12","key":"10086_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751\u2013760.","journal-title":"Nature Nanotechnology"},{"issue":"9","key":"10086_CR13","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1039\/D0NA00187B","volume":"2","author":"C Naud","year":"2020","unstructured":"Naud, C., et al. (2020). Cancer treatment by magneto-mechanical effect of particles, a review. Nanoscale Advances, 2(9), 3632\u20133655.","journal-title":"Nanoscale Advances"},{"issue":"3","key":"10086_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/acscentsci.5b00182","volume":"1","author":"CJ Murphy","year":"2015","unstructured":"Murphy, C. J., et al. (2015). Biological responses to engineered nanomaterials: Needs for the next decade. ACS Central Science, 1(3), 117\u2013123.","journal-title":"ACS Central Science"},{"issue":"1","key":"10086_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/0725513697051000014","volume":"51","author":"J Morton","year":"1997","unstructured":"Morton, J. (1997). Reviews. Thesis Eleven, 51(1), 131\u2013132.","journal-title":"Thesis Eleven"},{"issue":"2","key":"10086_CR16","first-page":"65","volume":"57","author":"A Ghossain","year":"2009","unstructured":"Ghossain, A., & Ghossain, M. A. (2009). History of mastectomy before and after Halsted. Le Journal medical libanais. The Lebanese medical journal, 57(2), 65\u201371.","journal-title":"The Lebanese medical journal"},{"issue":"4","key":"10086_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.oraloncology.2012.11.004","volume":"49","author":"R Sankaranarayanan","year":"2013","unstructured":"Sankaranarayanan, R., et al. (2013). Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala India. Oral Oncology, 49(4), 314\u2013321.","journal-title":"Oral Oncology"},{"issue":"5","key":"10086_CR18","first-page":"437","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang, K., & Tepper, J. E. (2021). Radiation therapy-associated toxicity: Etiology, management, and prevention. CA: A Cancer Journal for Clinicians, 71(5), 437\u2013454.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"9","key":"10086_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/0141076815595794","volume":"108","author":"SM Bird","year":"2015","unstructured":"Bird, S. M. (2015). The 1959 meeting in Vienna on controlled clinical trials\u2013A methodological landmark. Journal of the Royal Society of Medicine, 108(9), 372\u2013375.","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"1","key":"10086_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3857\/roj.2018.00122","volume":"36","author":"B Cho","year":"2018","unstructured":"Cho, B. (2018). Intensity-modulated radiation therapy: A review with a physics perspective. Radiation Oncology Journal, 36(1), 1\u201310.","journal-title":"Radiation Oncology Journal"},{"issue":"3","key":"10086_CR21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","volume":"132","author":"LS Goodman","year":"1946","unstructured":"Goodman, L. S., et al. (1946). Nitrogen mustard therapy: Use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for hodgkin\u2019s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Association, 132(3), 126\u2013132.","journal-title":"Journal of the American Medical Association"},{"issue":"23","key":"10086_CR22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJM194806032382301","volume":"238","author":"S Farber","year":"1948","unstructured":"Farber, S., et al. (1948). Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New England Journal of Medicine, 238(23), 787\u2013793.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10086_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9258(18)56438-3","volume":"183","author":"GH Hitchings","year":"1950","unstructured":"Hitchings, G. H., et al. (1950). Antagonists of nucleic acid derivatives: I The Lactobacillus casei model. Journal of Biological Chemistry, 183(1), 1\u20139.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10086_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jcm4010127","volume":"4","author":"JD De Rooij","year":"2015","unstructured":"De Rooij, J. D., Zwaan, C. M., & van den Heuvel-Eibrink, M. (2015). Pediatric AML: From biology to clinical management. Journal of clinical medicine, 4(1), 127\u2013149.","journal-title":"Journal of clinical medicine"},{"issue":"S1","key":"10086_CR25","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.5045\/br.2020.S002","volume":"55","author":"H Kim","year":"2020","unstructured":"Kim, H. (2020). Treatments for children and adolescents with AML. Blood research, 55(S1), S5\u2013S13.","journal-title":"Blood research"},{"issue":"3","key":"10086_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann, P. C., et al. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1(3), 313\u2013323.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10086_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/sj.leu.2403665","volume":"19","author":"A Slats","year":"2005","unstructured":"Slats, A., et al. (2005). Causes of death\u2013other than progressive leukemia\u2013in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): The Dutch Childhood Oncology Group experience. Leukemia, 19(4), 537\u2013544.","journal-title":"Leukemia"},{"issue":"1","key":"10086_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0493-5","volume":"36","author":"R Bista","year":"2017","unstructured":"Bista, R., et al. (2017). Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells. Journal of Experimental & Clinical Cancer Research, 36(1), 1\u201314.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10086_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcell.2015.00016","volume":"3","author":"E Aleem","year":"2015","unstructured":"Aleem, E., & Arceci, R. J. (2015). Targeting cell cycle regulators in hematologic malignancies. Frontiers in cell and developmental biology, 3, 16.","journal-title":"Frontiers in cell and developmental biology"},{"key":"10086_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee, Y. T., Tan, Y. J., & Oon, C. E. (2018). Molecular targeted therapy: Treating cancer with specificity. European journal of pharmacology, 834, 188\u2013196.","journal-title":"European journal of pharmacology"},{"issue":"1","key":"10086_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5732\/cjc.010.10553","volume":"30","author":"L Yan","year":"2011","unstructured":"Yan, L., Rosen, N., & Arteaga, C. (2011). Targeted cancer therapies. Chinese journal of cancer, 30(1), 1.","journal-title":"Chinese journal of cancer"},{"key":"10086_CR32","doi-asserted-by":"publisher","first-page":"106087","DOI":"10.1016\/j.biocel.2021.106087","volume":"140","author":"MA Mansour","year":"2021","unstructured":"Mansour, M. A., Caputo, V. S., & Aleem, E. (2021). Highlights on selected growth factors and their receptors as promising anticancer drug targets. The International Journal of Biochemistry & Cell Biology, 140, 106087.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10086_CR33","doi-asserted-by":"publisher","first-page":"911063","DOI":"10.3389\/fnano.2022.911063","volume":"4","author":"AS Nadukkandy","year":"2022","unstructured":"Nadukkandy, A. S., et al. (2022). Tracing new landscapes in the arena of nanoparticle-based cancer immunotherapy. Frontiers in Nanotechnology, 4, 911063.","journal-title":"Frontiers in Nanotechnology"},{"issue":"13","key":"10086_CR34","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1088\/0022-3727\/36\/13\/201","volume":"36","author":"QA Pankhurst","year":"2003","unstructured":"Pankhurst, Q. A., et al. (2003). Applications of magnetic nanoparticles in biomedicine. Journal of physics D: Applied physics, 36(13), R167.","journal-title":"Journal of physics D: Applied physics"},{"key":"10086_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addr.2013.09.006","volume":"66","author":"Y Cheng","year":"2014","unstructured":"Cheng, Y., et al. (2014). Multifunctional nanoparticles for brain tumor imaging and therapy. Advanced drug delivery reviews, 66, 42\u201357.","journal-title":"Advanced drug delivery reviews"},{"issue":"7\u20138","key":"10086_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S1369-7021(11)70163-8","volume":"14","author":"ZR Stephen","year":"2011","unstructured":"Stephen, Z. R., Kievit, F. M., & Zhang, M. (2011). Magnetite nanoparticles for medical MR imaging. Materials Today, 14(7\u20138), 330\u2013338.","journal-title":"Materials Today"},{"key":"10086_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2014.08.002","volume":"18","author":"R Jin","year":"2014","unstructured":"Jin, R., et al. (2014). Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: Design considerations and clinical applications. Current opinion in pharmacology, 18, 18\u201327.","journal-title":"Current opinion in pharmacology"},{"issue":"3","key":"10086_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1748-0132(07)70084-1","volume":"2","author":"M Arruebo","year":"2007","unstructured":"Arruebo, M., et al. (2007). Magnetic nanoparticles for drug delivery. Nano Today, 2(3), 22\u201332.","journal-title":"Nano Today"},{"issue":"4","key":"10086_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13204-013-0216-y","volume":"4","author":"VV Mody","year":"2014","unstructured":"Mody, V. V., et al. (2014). Magnetic nanoparticle drug delivery systems for targeting tumor. Applied Nanoscience, 4(4), 385\u2013392.","journal-title":"Applied Nanoscience"},{"issue":"11","key":"10086_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.addr.2008.03.018","volume":"60","author":"C Sun","year":"2008","unstructured":"Sun, C., Lee, J. S., & Zhang, M. (2008). Magnetic nanoparticles in MR imaging and drug delivery. Advanced drug delivery reviews, 60(11), 1252\u20131265.","journal-title":"Advanced drug delivery reviews"},{"issue":"11","key":"10086_CR41","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7150\/thno.11544","volume":"5","author":"OL Gobbo","year":"2015","unstructured":"Gobbo, O. L., et al. (2015). Magnetic nanoparticles in cancer theranostics. Theranostics, 5(11), 1249.","journal-title":"Theranostics"},{"issue":"17","key":"10086_CR42","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1039\/C4CS00322E","volume":"44","author":"Y Gao","year":"2015","unstructured":"Gao, Y., et al. (2015). Emerging translational research on magnetic nanoparticles for regenerative medicine. Chemical Society Reviews, 44(17), 6306\u20136329.","journal-title":"Chemical Society Reviews"},{"issue":"36","key":"10086_CR43","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1039\/C7NR04914E","volume":"9","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., et al. (2017). Large-scale immuno-magnetic cell sorting of T cells based on a self-designed high-throughput system for potential clinical application. Nanoscale, 9(36), 13592\u201313599.","journal-title":"Nanoscale"},{"key":"10086_CR44","doi-asserted-by":"crossref","unstructured":"Cartmell, S., et al. (2005). Use of magnetic particles to apply mechanical forces for bone tissue engineering purposes. in Journal of Physics: Conference Series. IOP Publishing.","DOI":"10.1088\/1742-6596\/17\/1\/013"},{"issue":"2","key":"10086_CR45","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1021\/nn404954s","volume":"8","author":"C Sanchez","year":"2014","unstructured":"Sanchez, C., et al. (2014). Targeting a G-protein-coupled receptor overexpressed in endocrine tumors by magnetic nanoparticles to induce cell death. ACS Nano, 8(2), 1350\u20131363.","journal-title":"ACS Nano"},{"issue":"3","key":"10086_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40204-016-0054-6","volume":"5","author":"L Kafrouni","year":"2016","unstructured":"Kafrouni, L., & Savadogo, O. (2016). Recent progress on magnetic nanoparticles for magnetic hyperthermia. Progress in Biomaterials, 5(3), 147\u2013160.","journal-title":"Progress in Biomaterials"},{"issue":"45","key":"10086_CR47","doi-asserted-by":"publisher","first-page":"452001","DOI":"10.1088\/0957-4484\/25\/45\/452001","volume":"25","author":"S Dutz","year":"2014","unstructured":"Dutz, S., & Hergt, R. (2014). Magnetic particle hyperthermia\u2014A promising tumour therapy? Nanotechnology, 25(45), 452001.","journal-title":"Nanotechnology"},{"issue":"8","key":"10086_CR48","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tibtech.2009.04.003","volume":"27","author":"JL Corchero","year":"2009","unstructured":"Corchero, J. L., & Villaverde, A. (2009). Biomedical applications of distally controlled magnetic nanoparticles. Trends in biotechnology, 27(8), 468\u2013476.","journal-title":"Trends in biotechnology"},{"issue":"10","key":"10086_CR49","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2217\/nnm.12.133","volume":"7","author":"EA Vitol","year":"2012","unstructured":"Vitol, E. A., Novosad, V., & Rozhkova, E. A. (2012). Microfabricated magnetic structures for future medicine: From sensors to cell actuators. Nanomedicine, 7(10), 1611\u20131624.","journal-title":"Nanomedicine"},{"issue":"1","key":"10086_CR50","doi-asserted-by":"publisher","first-page":"011306","DOI":"10.1063\/1.5123716","volume":"7","author":"M Goiriena-Goikoetxea","year":"2020","unstructured":"Goiriena-Goikoetxea, M., et al. (2020). Disk-shaped magnetic particles for cancer therapy. Applied Physics Reviews, 7(1), 011306.","journal-title":"Applied Physics Reviews"},{"issue":"1","key":"10086_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-04154-1","volume":"7","author":"R Mansell","year":"2017","unstructured":"Mansell, R., et al. (2017). Magnetic particles with perpendicular anisotropy for mechanical cancer cell destruction. Scientific reports, 7(1), 1\u20137.","journal-title":"Scientific reports"},{"key":"10086_CR52","doi-asserted-by":"publisher","first-page":"587012","DOI":"10.3389\/fmolb.2020.587012","volume":"7","author":"G Sanit\u00e0","year":"2020","unstructured":"Sanit\u00e0, G., Carrese, B., & Lamberti, A. (2020). Nanoparticle surface functionalization: How to improve biocompatibility and cellular internalization. Frontiers in Molecular Biosciences, 7, 587012.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"10086_CR53","first-page":"3393","volume":"12","author":"I Rea","year":"1840","unstructured":"Rea, I., et al. (1840). 2014 Diatomite biosilica nanocarriers for siRNA transport inside cancer cells. Biochimica et Biophysica Acta (BBA)-General Subjects, 12, 3393\u20133403.","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"10086_CR54","doi-asserted-by":"publisher","first-page":"115333","DOI":"10.1016\/j.carbpol.2019.115333","volume":"227","author":"S Banihashem","year":"2020","unstructured":"Banihashem, S., Nezhati, M. N., & Panahia, H. A. (2020). Synthesis of chitosan-grafted-poly (N-vinylcaprolactam) coated on the thiolated gold nanoparticles surface for controlled release of cisplatin. Carbohydrate polymers, 227, 115333.","journal-title":"Carbohydrate polymers"},{"issue":"14","key":"10086_CR55","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1039\/C5CC07107K","volume":"52","author":"KV Korpany","year":"2016","unstructured":"Korpany, K. V., et al. (2016). One-step ligand exchange and switching from hydrophobic to water-stable hydrophilic superparamagnetic iron oxide nanoparticles by mechanochemical milling. Chemical Communications, 52(14), 3054\u20133057.","journal-title":"Chemical Communications"},{"issue":"90","key":"10086_CR56","doi-asserted-by":"publisher","first-page":"13506","DOI":"10.1039\/C9CC07131H","volume":"55","author":"L Yue","year":"2019","unstructured":"Yue, L., et al. (2019). Gold nanorods with a noncovalently tailorable surface for multi-modality image-guided chemo-photothermal cancer therapy. Chemical Communications, 55(90), 13506\u201313509.","journal-title":"Chemical Communications"},{"issue":"4","key":"10086_CR57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.apt.2019.01.008","volume":"30","author":"M Sakaguchi","year":"2019","unstructured":"Sakaguchi, M., et al. (2019). Surface modification of Fe3O4 nanoparticles with dextran via a coupling reaction between naked Fe3O4 mechano-cation and naked dextran mechano-anion: A new mechanism of covalent bond formation. Advanced Powder Technology, 30(4), 795\u2013806.","journal-title":"Advanced Powder Technology"},{"issue":"1","key":"10086_CR58","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3762\/bjnano.10.108","volume":"10","author":"M \u015awi\u0119tek","year":"2019","unstructured":"\u015awi\u0119tek, M., et al. (2019). Scavenging of reactive oxygen species by phenolic compound-modified maghemite nanoparticles. Beilstein journal of nanotechnology, 10(1), 1073\u20131088.","journal-title":"Beilstein journal of nanotechnology"},{"issue":"4","key":"10086_CR59","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/molecules23040826","volume":"23","author":"C-Y Zhao","year":"2018","unstructured":"Zhao, C.-Y., et al. (2018). Nanotechnology for cancer therapy based on chemotherapy. Molecules, 23(4), 826.","journal-title":"Molecules"},{"issue":"3","key":"10086_CR60","doi-asserted-by":"publisher","first-page":"e58619","DOI":"10.1371\/journal.pone.0058619","volume":"8","author":"U Katragadda","year":"2013","unstructured":"Katragadda, U., et al. (2013). Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: Pharmacokinetics, efficacy and metabolomic analysis. PLoS One, 8(3), e58619.","journal-title":"PLoS One"},{"key":"10086_CR61","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.2147\/IJN.S147028","volume":"12","author":"K Liu","year":"2017","unstructured":"Liu, K., et al. (2017). Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery. International journal of nanomedicine, 12, 8239.","journal-title":"International journal of nanomedicine"},{"issue":"6","key":"10086_CR62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","volume":"36","author":"J Araujo","year":"2010","unstructured":"Araujo, J., & Logothetis, C. (2010). Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors. Cancer treatment reviews, 36(6), 492\u2013500.","journal-title":"Cancer treatment reviews"},{"issue":"6","key":"10086_CR63","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ajps.2021.08.001","volume":"16","author":"L Yang","year":"2021","unstructured":"Yang, L., et al. (2021). Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo. Asian journal of pharmaceutical sciences, 16(6), 762\u2013771.","journal-title":"Asian journal of pharmaceutical sciences"},{"issue":"16","key":"10086_CR64","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.3390\/nano12162826","volume":"12","author":"S Siddique","year":"2022","unstructured":"Siddique, S., & Chow, J. C. (2022). Recent advances in functionalized nanoparticles in cancer theranostics. Nanomaterials, 12(16), 2826.","journal-title":"Nanomaterials"},{"issue":"1","key":"10086_CR65","doi-asserted-by":"publisher","first-page":"20150086","DOI":"10.1098\/rsfs.2015.0086","volume":"6","author":"Y Li","year":"2016","unstructured":"Li, Y., et al. (2016). Cell and nanoparticle transport in tumour microvasculature: The role of size, shape and surface functionality of nanoparticles. Interface focus, 6(1), 20150086.","journal-title":"Interface focus"},{"issue":"1","key":"10086_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41524-020-00366-8","volume":"6","author":"NR Stillman","year":"2020","unstructured":"Stillman, N. R., et al. (2020). In silico modelling of cancer nanomedicine, across scales and transport barriers. NPJ Computational Materials, 6(1), 1\u201310.","journal-title":"NPJ Computational Materials"},{"issue":"3","key":"10086_CR67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12609-010-0020-6","volume":"2","author":"AH Chauviere","year":"2010","unstructured":"Chauviere, A. H., et al. (2010). Mathematical oncology: How are the mathematical and physical sciences contributing to the war on breast cancer? Current breast cancer reports, 2(3), 121\u2013129.","journal-title":"Current breast cancer reports"},{"issue":"1","key":"10086_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ncponc1237","volume":"6","author":"TS Deisboeck","year":"2009","unstructured":"Deisboeck, T. S., et al. (2009). In silico cancer modeling: Is it ready for prime time? Nature Clinical Practice Oncology, 6(1), 34\u201342.","journal-title":"Nature Clinical Practice Oncology"},{"issue":"1","key":"10086_CR69","first-page":"115","volume":"3","author":"KA Rejniak","year":"2011","unstructured":"Rejniak, K. A., & Anderson, A. R. (2011). Hybrid models of tumor growth. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 3(1), 115\u2013125.","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"issue":"2","key":"10086_CR70","first-page":"159","volume":"1","author":"G An","year":"2009","unstructured":"An, G., et al. (2009). Agent-based models in translational systems biology. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 1(2), 159\u2013171.","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"key":"10086_CR71","unstructured":"Konukoglu, E., et al. (2010). Mathematical and computational biology. In: T. S. Deisboeck, G. Stamatakos (Eds.), Multiscale cancer modeling. CRC Press."},{"issue":"1","key":"10086_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/pr7010037","volume":"7","author":"K-A Norton","year":"2019","unstructured":"Norton, K.-A., et al. (2019). Multiscale agent-based and hybrid modeling of the tumor immune microenvironment. Processes, 7(1), 37.","journal-title":"Processes"},{"key":"10086_CR73","doi-asserted-by":"publisher","unstructured":"Rejniak, K. A., & Anderson, A. R. A. (2011). Hybrid models of tumor growth. Wire Mechanism of Diseae, 3(1), 115\u2013125. https:\/\/doi.org\/10.1002\/wsbm.102","DOI":"10.1002\/wsbm.102"},{"issue":"17","key":"10086_CR74","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1158\/0008-5472.CAN-08-3957","volume":"69","author":"D Basanta","year":"2009","unstructured":"Basanta, D., et al. (2009). The role of transforming growth factor-\u03b2\u2013mediated tumor-stroma interactions in prostate cancer progression: An integrative approach. Cancer research, 69(17), 7111\u20137120.","journal-title":"Cancer research"},{"issue":"12","key":"10086_CR75","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/sj.bjc.6605071","volume":"100","author":"H Enderling","year":"2009","unstructured":"Enderling, H., Hlatky, L., & Hahnfeldt, P. (2009). Migration rules: Tumours are conglomerates of self-metastases. British journal of cancer, 100(12), 1917\u20131925.","journal-title":"British journal of cancer"},{"issue":"3","key":"10086_CR76","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jtbi.2007.01.011","volume":"246","author":"A Bankhead III","year":"2007","unstructured":"Bankhead, A., III., Magnuson, N. S., & Heckendorn, R. B. (2007). Cellular automaton simulation examining progenitor hierarchy structure effects on mammary ductal carcinoma in situ. Journal of theoretical biology, 246(3), 491\u2013498.","journal-title":"Journal of theoretical biology"},{"issue":"1","key":"10086_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-2-110","volume":"2","author":"JA Engelberg","year":"2008","unstructured":"Engelberg, J. A., Ropella, G. E., & Hunt, C. A. (2008). Essential operating principles for tumor spheroid growth. BMC systems biology, 2(1), 1\u201319.","journal-title":"BMC systems biology"},{"issue":"10","key":"10086_CR78","doi-asserted-by":"publisher","first-page":"e7190","DOI":"10.1371\/journal.pone.0007190","volume":"4","author":"A Shirinifard","year":"2009","unstructured":"Shirinifard, A., et al. (2009). 3D multi-cell simulation of tumor growth and angiogenesis. PLoS One, 4(10), e7190.","journal-title":"PLoS One"},{"issue":"12","key":"10086_CR79","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1529\/biophysj.108.140624","volume":"95","author":"BM Rubenstein","year":"2008","unstructured":"Rubenstein, B. M., & Kaufman, L. J. (2008). The role of extracellular matrix in glioma invasion: A cellular Potts model approach. Biophysical journal, 95(12), 5661\u20135680.","journal-title":"Biophysical journal"},{"issue":"5","key":"10086_CR80","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2184.2009.00627.x","volume":"42","author":"IM Van Leeuwen","year":"2009","unstructured":"Van Leeuwen, I. M., et al. (2009). An integrative computational model for intestinal tissue renewal. Cell proliferation, 42(5), 617\u2013636.","journal-title":"Cell proliferation"},{"key":"10086_CR81","doi-asserted-by":"publisher","unstructured":"Toma, A., et al. (2012). A novel method for simulating the extracellular matrix in models of tumour growth. Computational and Mathematical Methods in Medicine, 2012, 1\u201311. https:\/\/doi.org\/10.1155\/2012\/109019","DOI":"10.1155\/2012\/109019"},{"key":"10086_CR82","doi-asserted-by":"crossref","unstructured":"Wang, Z., et al. (2015). Simulating cancer growth with multiscale agent-based modeling. in Seminars in cancer biology. Elsevier.","DOI":"10.1016\/j.semcancer.2014.04.001"},{"issue":"1","key":"10086_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-15767-6","volume":"12","author":"A Lapin","year":"2022","unstructured":"Lapin, A., et al. (2022). Integrating a dynamic central metabolism model of cancer cells with a hybrid 3D multiscale model for vascular hepatocellular carcinoma growth. Scientific Reports, 12(1), 1\u201313.","journal-title":"Scientific Reports"},{"issue":"1","key":"10086_CR84","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jtbi.2010.10.016","volume":"269","author":"X Zhu","year":"2011","unstructured":"Zhu, X., et al. (2011). Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study. Journal of theoretical biology, 269(1), 138\u2013149.","journal-title":"Journal of theoretical biology"},{"key":"10086_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mvr.2015.02.007","volume":"99","author":"M Sefidgar","year":"2015","unstructured":"Sefidgar, M., et al. (2015). Numerical modeling of drug delivery in a dynamic solid tumor microvasculature. Microvascular research, 99, 43\u201356.","journal-title":"Microvascular research"},{"issue":"6","key":"10086_CR86","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.bpj.2018.07.038","volume":"115","author":"PN Shah","year":"2018","unstructured":"Shah, P. N., et al. (2018). Extravasation of Brownian spheroidal nanoparticles through vascular pores. Biophysical journal, 115(6), 1103\u20131115.","journal-title":"Biophysical journal"},{"issue":"1","key":"10086_CR87","first-page":"2539","volume":"9","author":"H Nehoff","year":"2014","unstructured":"Nehoff, H., et al. (2014). Nanomedicine for drug targeting: Strategies beyond the enhanced permeability and retention effect. International journal of nanomedicine, 9(1), 2539\u20132555.","journal-title":"International journal of nanomedicine"},{"key":"10086_CR88","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jtbi.2018.06.014","volume":"454","author":"S Hamis","year":"2018","unstructured":"Hamis, S., Nithiarasu, P., & Powathil, G. G. (2018). What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance. Journal of theoretical biology, 454, 253\u2013267.","journal-title":"Journal of theoretical biology"},{"issue":"1","key":"10086_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41524-017-0050-y","volume":"3","author":"S Angioletti-Uberti","year":"2017","unstructured":"Angioletti-Uberti, S. (2017). Theory, simulations and the design of functionalized nanoparticles for biomedical applications: A soft matter perspective. npj Computational Materials, 3(1), 1\u201315.","journal-title":"npj Computational Materials"},{"issue":"11","key":"10086_CR90","first-page":"641","volume":"4","author":"SD Finley","year":"2015","unstructured":"Finley, S. D., et al. (2015). Pharmacokinetics of anti-VEGF agent aflibercept in cancer predicted by data-driven molecular-detailed model. CPT: Pharmacometrics & systems pharmacology, 4(11), 641\u2013649.","journal-title":"CPT: Pharmacometrics & systems pharmacology"},{"key":"10086_CR91","doi-asserted-by":"crossref","unstructured":"Longmire, M., Choyke, P. L., & Kobayashi, H. (2008). Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicines, 3(5), 703\u2013717.","DOI":"10.2217\/17435889.3.5.703"},{"issue":"4","key":"10086_CR92","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","volume":"10","author":"HH Gustafson","year":"2015","unstructured":"Gustafson, H. H., et al. (2015). Nanoparticle uptake: The phagocyte problem. Nano Today, 10(4), 487\u2013510.","journal-title":"Nano Today"},{"issue":"2","key":"10086_CR93","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10237-013-0497-9","volume":"13","author":"DA Fedosov","year":"2014","unstructured":"Fedosov, D. A., Noguchi, H., & Gompper, G. (2014). Multiscale modeling of blood flow: From single cells to blood rheology. Biomechanics and modeling in mechanobiology, 13(2), 239\u2013258.","journal-title":"Biomechanics and modeling in mechanobiology"},{"issue":"24","key":"10086_CR94","doi-asserted-by":"publisher","first-page":"12B620_1","DOI":"10.1063\/1.4936908","volume":"143","author":"H Lopez","year":"2015","unstructured":"Lopez, H., & Lobaskin, V. (2015). Coarse-grained model of adsorption of blood plasma proteins onto nanoparticles. The Journal of chemical physics, 143(24), 12B620_1.","journal-title":"The Journal of chemical physics"},{"issue":"41","key":"10086_CR95","first-page":"414019","volume":"28","author":"Q Shao","year":"2016","unstructured":"Shao, Q., & Hall, C. K. (2016). Protein adsorption on nanoparticles: Model development using computer simulation. Journal of Physics: Condensed Matter, 28(41), 414019.","journal-title":"Journal of Physics: Condensed Matter"},{"key":"10086_CR96","doi-asserted-by":"publisher","first-page":"105210","DOI":"10.1016\/j.cmpb.2019.105210","volume":"186","author":"R Maleki","year":"2020","unstructured":"Maleki, R., et al. (2020). pH-sensitive loading\/releasing of doxorubicin using single-walled carbon nanotube and multi-walled carbon nanotube: A molecular dynamics study. Computer methods and programs in biomedicine, 186, 105210.","journal-title":"Computer methods and programs in biomedicine"},{"issue":"1","key":"10086_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep04871","volume":"4","author":"K M\u00fcller","year":"2014","unstructured":"M\u00fcller, K., Fedosov, D. A., & Gompper, G. (2014). Margination of micro-and nano-particles in blood flow and its effect on drug delivery. Scientific reports, 4(1), 1\u20138.","journal-title":"Scientific reports"},{"key":"10086_CR98","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jtbi.2014.04.012","volume":"355","author":"M Wu","year":"2014","unstructured":"Wu, M., et al. (2014). The effect of interstitial pressure on therapeutic agent transport: Coupling with the tumor blood and lymphatic vascular systems. Journal of theoretical biology, 355, 194\u2013207.","journal-title":"Journal of theoretical biology"},{"issue":"3","key":"10086_CR99","doi-asserted-by":"publisher","first-page":"20180063","DOI":"10.1098\/rsfs.2018.0063","volume":"9","author":"PA Wijeratne","year":"2019","unstructured":"Wijeratne, P. A., & Vavourakis, V. (2019). A quantitative in silico platform for simulating cytotoxic and nanoparticle drug delivery to solid tumours. Interface Focus, 9(3), 20180063.","journal-title":"Interface Focus"},{"issue":"1","key":"10086_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41427-021-00320-0","volume":"13","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Ma, G., & Wei, W. (2021). Simulation of nanoparticles interacting with a cell membrane: Probing the structural basis and potential biomedical application. NPG Asia Materials, 13(1), 1\u201318.","journal-title":"NPG Asia Materials"},{"issue":"9\u201310","key":"10086_CR101","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/smll.201202111","volume":"9","author":"D Ling","year":"2013","unstructured":"Ling, D., & Hyeon, T. (2013). Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small (Weinheim an der Bergstrasse, Germany), 9(9\u201310), 1450\u20131466.","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"7","key":"10086_CR102","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1080\/21691401.2017.1389746","volume":"46","author":"M Samadishadlou","year":"2018","unstructured":"Samadishadlou, M., et al. (2018). Magnetic carbon nanotubes: Preparation, physical properties, and applications in biomedicine. Artificial cells, nanomedicine, and biotechnology, 46(7), 1314\u20131330.","journal-title":"Artificial cells, nanomedicine, and biotechnology"},{"issue":"2","key":"10086_CR103","doi-asserted-by":"publisher","first-page":"N18","DOI":"10.1227\/01.neu.0000452316.07108.d2","volume":"75","author":"I Bodhinayake","year":"2014","unstructured":"Bodhinayake, I., Ottenhausen, M., & Boockvar, J. A. (2014). Targeting a heterogeneous tumor: The promise of the interleukin-13 receptor \u03b12. Neurosurgery, 75(2), N18\u2013N19.","journal-title":"Neurosurgery"},{"issue":"15","key":"10086_CR104","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1158\/0008-5472.CAN-10-1022","volume":"70","author":"CG Hadjipanayis","year":"2010","unstructured":"Hadjipanayis, C. G., et al. (2010). EGFRvIII antibody\u2013conjugated iron oxide nanoparticles for magnetic resonance imaging\u2013guided convection-enhanced delivery and targeted therapy of glioblastomaEGFRvIII-targeted therapy of GBM by IONPs after CED. Cancer research, 70(15), 6303\u20136312.","journal-title":"Cancer research"},{"issue":"24","key":"10086_CR105","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1007\/s10853-011-5812-1","volume":"46","author":"E Prats-Alfonso","year":"2011","unstructured":"Prats-Alfonso, E., & Albericio, F. (2011). Functionalization of gold surfaces: Recent developments and applications. Journal of materials science, 46(24), 7643\u20137648.","journal-title":"Journal of materials science"},{"issue":"8","key":"10086_CR106","doi-asserted-by":"publisher","first-page":"180633","DOI":"10.1098\/rsos.180633","volume":"5","author":"J Verma","year":"2018","unstructured":"Verma, J., & Bhattacharya, A. (2018). Development of coating formulation with silica\u2013titania core\u2013shell nanoparticles against pathogenic fungus. Royal Society Open Science, 5(8), 180633.","journal-title":"Royal Society Open Science"},{"issue":"9","key":"10086_CR107","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1039\/D0NA00387E","volume":"2","author":"J Verma","year":"2020","unstructured":"Verma, J., et al. (2020). Super protective anti-bacterial coating development with silica\u2013titania nano core\u2013shells. Nanoscale Advances, 2(9), 4093\u20134105.","journal-title":"Nanoscale Advances"},{"issue":"3","key":"10086_CR108","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bbrc.2015.08.022","volume":"468","author":"R Tietze","year":"2015","unstructured":"Tietze, R., et al. (2015). Magnetic nanoparticle-based drug delivery for cancer therapy. Biochemical and biophysical research communications, 468(3), 463\u2013470.","journal-title":"Biochemical and biophysical research communications"},{"key":"10086_CR109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2015.09.038","volume":"219","author":"YI Golovin","year":"2015","unstructured":"Golovin, Y. I., et al. (2015). Towards nanomedicines of the future: Remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields. Journal of Controlled Release, 219, 43\u201360.","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10086_CR110","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nnano.2007.418","volume":"3","author":"RJ Mannix","year":"2008","unstructured":"Mannix, R. J., et al. (2008). Nanomagnetic actuation of receptor-mediated signal transduction. Nature nanotechnology, 3(1), 36\u201340.","journal-title":"Nature nanotechnology"},{"issue":"2","key":"10086_CR111","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1021\/acsnano.5b07118","volume":"10","author":"A Tay","year":"2016","unstructured":"Tay, A., et al. (2016). Induction of calcium influx in cortical neural networks by nanomagnetic forces. ACS Nano, 10(2), 2331\u20132341.","journal-title":"ACS Nano"},{"issue":"27","key":"10086_CR112","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1002\/adma.201504845","volume":"28","author":"D Kilinc","year":"2016","unstructured":"Kilinc, D., Dennis, C. L., & Lee, G. U. (2016). Bio-nano-magnetic materials for localized mechanochemical stimulation of cell growth and death. Advanced Materials, 28(27), 5672\u20135680.","journal-title":"Advanced Materials"},{"issue":"2","key":"10086_CR113","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1109\/TBME.2007.899347","volume":"55","author":"ZG Forbes","year":"2008","unstructured":"Forbes, Z. G., et al. (2008). Validation of high gradient magnetic field based drug delivery to magnetizable implants under flow. IEEE Transactions on Biomedical Engineering, 55(2), 643\u2013649.","journal-title":"IEEE Transactions on Biomedical Engineering"},{"issue":"4","key":"10086_CR114","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.bbrc.2010.02.081","volume":"393","author":"T Mizuki","year":"2010","unstructured":"Mizuki, T., et al. (2010). Activity of an enzyme immobilized on superparamagnetic particles in a rotational magnetic field. Biochemical and biophysical research communications, 393(4), 779\u2013782.","journal-title":"Biochemical and biophysical research communications"},{"issue":"2","key":"10086_CR115","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1039\/D1NA00474C","volume":"4","author":"S Lopez","year":"2022","unstructured":"Lopez, S., et al. (2022). Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields. Nanoscale Advances, 4(2), 421\u2013436.","journal-title":"Nanoscale Advances"},{"issue":"21","key":"10086_CR116","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1039\/D1NA00461A","volume":"3","author":"C Th\u00e9bault","year":"2021","unstructured":"Th\u00e9bault, C., et al. (2021). Magneto-mechanical treatment of human glioblastoma cells with engineered iron oxide powder microparticles for triggering apoptosis. Nanoscale Advances, 3(21), 6213\u20136222.","journal-title":"Nanoscale Advances"},{"issue":"2","key":"10086_CR117","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nmat2591","volume":"9","author":"D-H Kim","year":"2010","unstructured":"Kim, D.-H., et al. (2010). Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction. Nature materials, 9(2), 165\u2013171.","journal-title":"Nature materials"},{"issue":"4","key":"10086_CR118","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nmat2399","volume":"8","author":"H Ade","year":"2009","unstructured":"Ade, H., & Stoll, H. (2009). Near-edge X-ray absorption fine-structure microscopy of organic and magnetic materials. Nature materials, 8(4), 281\u2013290.","journal-title":"Nature materials"},{"issue":"4","key":"10086_CR119","doi-asserted-by":"publisher","first-page":"485","DOI":"10.7150\/thno.13411","volume":"6","author":"F Wo","year":"2016","unstructured":"Wo, F., et al. (2016). A multimodal system with synergistic effects of magneto-mechanical, photothermal, photodynamic and chemo therapies of cancer in graphene-quantum dot-coated hollow magnetic nanospheres. Theranostics, 6(4), 485.","journal-title":"Theranostics"},{"issue":"23","key":"10086_CR120","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.1021\/ja4013497","volume":"135","author":"Q Tian","year":"2013","unstructured":"Tian, Q., et al. (2013). Sub-10 nm Fe3O4@ Cu2\u2013x S core\u2013shell nanoparticles for dual-modal imaging and photothermal therapy. Journal of the American Chemical Society, 135(23), 8571\u20138577.","journal-title":"Journal of the American Chemical Society"},{"key":"10086_CR121","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.colsurfb.2014.07.043","volume":"122","author":"X Wang","year":"2014","unstructured":"Wang, X., et al. (2014). Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery. Colloids and Surfaces B: Biointerfaces, 122, 638\u2013644.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"1","key":"10086_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01096-0","volume":"14","author":"Z Cheng","year":"2021","unstructured":"Cheng, Z., et al. (2021). Nanomaterials for cancer therapy: Current progress and perspectives. Journal of Hematology & Oncology, 14(1), 1\u201327.","journal-title":"Journal of Hematology & Oncology"},{"key":"10086_CR123","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","volume":"60","author":"F Masood","year":"2016","unstructured":"Masood, F. (2016). Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Materials Science and Engineering: C, 60, 569\u2013578.","journal-title":"Materials Science and Engineering: C"},{"key":"10086_CR124","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.colsurfb.2013.05.020","volume":"111","author":"V Vijayan","year":"2013","unstructured":"Vijayan, V., et al. (2013). Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: In vitro and in vivo studies. Colloids and Surfaces B: Biointerfaces, 111, 150\u2013155.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"5","key":"10086_CR125","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2174\/1389201033489694","volume":"4","author":"VP Shastri","year":"2003","unstructured":"Shastri, V. P. (2003). Non-degradable biocompatible polymers in medicine: Past, present and future. Current pharmaceutical biotechnology, 4(5), 331\u2013337.","journal-title":"Current pharmaceutical biotechnology"},{"key":"10086_CR126","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.actbio.2017.02.019","volume":"53","author":"S Mart\u00edn-Salda\u00f1a","year":"2017","unstructured":"Mart\u00edn-Salda\u00f1a, S., et al. (2017). Polymeric nanoparticles loaded with dexamethasone or \u03b1-tocopheryl succinate to prevent cisplatin-induced ototoxicity. Acta biomaterialia, 53, 199\u2013210.","journal-title":"Acta biomaterialia"},{"key":"10086_CR127","doi-asserted-by":"publisher","first-page":"625084","DOI":"10.3389\/fphar.2021.625084","volume":"12","author":"S Bao","year":"2021","unstructured":"Bao, S., et al. (2021). Dual targeting EGFR and STAT3 with erlotinib and alantolactone co-loaded PLGA nanoparticles for pancreatic cancer treatment. Frontiers in pharmacology, 12, 625084.","journal-title":"Frontiers in pharmacology"},{"issue":"2","key":"10086_CR128","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.ijpharm.2013.05.018","volume":"454","author":"D Le Broc-Ryckewaert","year":"2013","unstructured":"Le Broc-Ryckewaert, D., et al. (2013). Development of innovative paclitaxel-loaded small PLGA nanoparticles: Study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. International journal of pharmaceutics, 454(2), 712\u2013719.","journal-title":"International journal of pharmaceutics"},{"issue":"3","key":"10086_CR129","doi-asserted-by":"publisher","first-page":"155932581987258","DOI":"10.1177\/1559325819872583","volume":"17","author":"X Zhang","year":"2019","unstructured":"Zhang, X., et al. (2019). Trastuzumab-coated nanoparticles loaded with docetaxel for breast cancer therapy. Dose-Response, 17(3), 1559325819872583.","journal-title":"Dose-Response"},{"issue":"8","key":"10086_CR130","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1002\/ange.201813702","volume":"131","author":"Y Liu","year":"2019","unstructured":"Liu, Y., et al. (2019). One-dimensional Fe2P acts as a Fenton agent in response to NIR II light and ultrasound for deep tumor synergetic theranostics. Angewandte Chemie, 131(8), 2429\u20132434.","journal-title":"Angewandte Chemie"},{"issue":"2","key":"10086_CR131","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","volume":"148","author":"F Danhier","year":"2010","unstructured":"Danhier, F., Feron, O., & Pr\u00e9at, V. (2010). To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of controlled release, 148(2), 135\u2013146.","journal-title":"Journal of controlled release"},{"key":"10086_CR132","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/DDDT.S122984","volume":"11","author":"J-S Choi","year":"2017","unstructured":"Choi, J.-S., & Park, J.-S. (2017). Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting. Drug design, development and therapy, 11, 17.","journal-title":"Drug design, development and therapy"},{"issue":"4","key":"10086_CR133","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jmb.2007.05.011","volume":"371","author":"Y Zhou","year":"2007","unstructured":"Zhou, Y., et al. (2007). Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. Journal of molecular biology, 371(4), 934\u2013947.","journal-title":"Journal of molecular biology"},{"issue":"3","key":"10086_CR134","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.nano.2007.07.001","volume":"3","author":"R Bhattacharya","year":"2007","unstructured":"Bhattacharya, R., et al. (2007). Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomedicine: Nanotechnology, Biology and Medicine, 3(3), 224\u2013238.","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"key":"10086_CR135","doi-asserted-by":"crossref","unstructured":"Raj, S., et al. (2021). Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy. Seminars in Cancer Biology, 69, 66\u2013177.","DOI":"10.1016\/j.semcancer.2019.11.002"},{"issue":"1","key":"10086_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"F Chen","year":"2015","unstructured":"Chen, F., et al. (2015). New horizons in tumor microenvironment biology: Challenges and opportunities. BMC medicine, 13(1), 1\u201314.","journal-title":"BMC medicine"},{"key":"10086_CR137","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","volume":"65","author":"C Belli","year":"2018","unstructured":"Belli, C., et al. (2018). Targeting the microenvironment in solid tumors. Cancer treatment reviews, 65, 22\u201332.","journal-title":"Cancer treatment reviews"},{"key":"10086_CR138","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2017.04.026","volume":"256","author":"X Hu","year":"2017","unstructured":"Hu, X., et al. (2017). Nanotechnology based therapeutic modality to boost anti-tumor immunity and collapse tumor defense. Journal of Controlled Release, 256, 26\u201345.","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10086_CR139","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci, M., et al. (2021). The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chemical reviews, 121(3), 1746\u20131803.","journal-title":"Chemical reviews"},{"key":"10086_CR140","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu, T., & Dai, Y. (2017). Tumor microenvironment and therapeutic response. Cancer letters, 387, 61\u201368.","journal-title":"Cancer letters"},{"issue":"7","key":"10086_CR141","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bioactmat.2020.12.010","volume":"6","author":"M Yang","year":"2021","unstructured":"Yang, M., et al. (2021). The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioactive materials, 6(7), 1973\u20131987.","journal-title":"Bioactive materials"},{"issue":"1","key":"10086_CR142","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh, K., & Massagu\u00e9, J. (2021). Targeting metastatic cancer. Nature medicine, 27(1), 34\u201344.","journal-title":"Nature medicine"},{"key":"10086_CR143","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fphar.2018.01230","volume":"9","author":"C Fernandes","year":"2018","unstructured":"Fernandes, C., Suares, D., & Yergeri, M. C. (2018). Tumor microenvironment targeted nanotherapy. Frontiers in pharmacology, 9, 1230.","journal-title":"Frontiers in pharmacology"},{"issue":"1","key":"10086_CR144","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","volume":"39","author":"K Palucka","year":"2013","unstructured":"Palucka, K., & Banchereau, J. (2013). Dendritic-cell-based therapeutic cancer vaccines. Immunity, 39(1), 38\u201348.","journal-title":"Immunity"},{"issue":"9","key":"10086_CR145","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","volume":"11","author":"I Melero","year":"2014","unstructured":"Melero, I., et al. (2014). Therapeutic vaccines for cancer: An overview of clinical trials. Nature reviews Clinical oncology, 11(9), 509\u2013524.","journal-title":"Nature reviews Clinical oncology"},{"issue":"3","key":"10086_CR146","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41596-019-0249-0","volume":"15","author":"DK Zhang","year":"2020","unstructured":"Zhang, D. K., Cheung, A. S., & Mooney, D. J. (2020). Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds. Nature Protocols, 15(3), 773\u2013798.","journal-title":"Nature Protocols"},{"issue":"1","key":"10086_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-57088-1","volume":"10","author":"R Otsuka","year":"2020","unstructured":"Otsuka, R., et al. (2020). Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival. Scientific reports, 10(1), 1\u20138.","journal-title":"Scientific reports"},{"issue":"11","key":"10086_CR148","doi-asserted-by":"publisher","first-page":"10724","DOI":"10.1021\/acsnano.7b04955","volume":"11","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q., et al. (2017). Biomimetic magnetosomes as versatile artificial antigen-presenting cells to potentiate T-cell-based anticancer therapy. ACS Nano, 11(11), 10724\u201310732.","journal-title":"ACS Nano"},{"issue":"5","key":"10086_CR149","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1021\/acs.nanolett.8b01071","volume":"18","author":"K Cheng","year":"2018","unstructured":"Cheng, K., et al. (2018). Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy. Nano letters, 18(5), 3250\u20133258.","journal-title":"Nano letters"},{"issue":"17","key":"10086_CR150","doi-asserted-by":"publisher","first-page":"1900101","DOI":"10.1002\/advs.201900101","volume":"6","author":"X Feng","year":"2019","unstructured":"Feng, X., et al. (2019). Immunomodulatory nanosystems. Advanced science, 6(17), 1900101.","journal-title":"Advanced science"},{"issue":"11","key":"10086_CR151","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1021\/acs.nanolett.8b02340","volume":"18","author":"Z Liu","year":"2018","unstructured":"Liu, Z., et al. (2018). Immunomodulating nanomedicine for cancer therapy. Nano letters, 18(11), 6655\u20136659.","journal-title":"Nano letters"},{"key":"10086_CR152","doi-asserted-by":"crossref","unstructured":"Li, K., et al. (2022). Targeting innate immune system by nanoparticles for cancer immunotherapy. Journal of Materials Chemistry B, 10, 1709\u20131733.","DOI":"10.1039\/D1TB02818A"},{"issue":"8","key":"10086_CR153","doi-asserted-by":"publisher","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","volume":"15","author":"S Gao","year":"2021","unstructured":"Gao, S., et al. (2021). Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: The horizons in cancer treatment. ACS Nano, 15(8), 12567\u201312603.","journal-title":"ACS Nano"},{"issue":"1","key":"10086_CR154","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., et al. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71(1), 7\u201333.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"7782","key":"10086_CR155","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J., & Hyman, D. M. (2019). A view on drug resistance in cancer. Nature, 575(7782), 299\u2013309.","journal-title":"Nature"},{"key":"10086_CR156","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.drup.2021.100769","volume":"57","author":"NA Hussein","year":"2021","unstructured":"Hussein, N. A., et al. (2021). The role of endolysosomal trafficking in anticancer drug resistance. Drug Resistance Updates, 57, 100769.","journal-title":"Drug Resistance Updates"},{"issue":"1","key":"10086_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-01746-w","volume":"21","author":"M Levin","year":"2021","unstructured":"Levin, M., et al. (2021). Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: Towards precision medicine overcoming drug resistance. Cancer cell international, 21(1), 1\u201316.","journal-title":"Cancer cell international"},{"issue":"4","key":"10086_CR158","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/pharmaceutics14040866","volume":"14","author":"SNA Bukhari","year":"2022","unstructured":"Bukhari, S. N. A. (2022). Emerging nanotherapeutic approaches to overcome drug resistance in cancers with update on clinical trials. Pharmaceutics, 14(4), 866.","journal-title":"Pharmaceutics"},{"issue":"5","key":"10086_CR159","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s43440-020-00138-7","volume":"72","author":"T Haider","year":"2020","unstructured":"Haider, T., et al. (2020). Drug resistance in cancer: Mechanisms and tackling strategies. Pharmacological Reports, 72(5), 1125\u20131151.","journal-title":"Pharmacological Reports"},{"key":"10086_CR160","doi-asserted-by":"publisher","first-page":"102681","DOI":"10.1016\/j.jddst.2021.102681","volume":"64","author":"Y Mao","year":"2021","unstructured":"Mao, Y., et al. (2021). Insight of nanomedicine strategies for a targeted delivery of nanotherapeutic cues to cope with the resistant types of cancer stem cells. Journal of Drug Delivery Science and Technology, 64, 102681.","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10086_CR161","doi-asserted-by":"publisher","first-page":"119667","DOI":"10.1016\/j.lfs.2021.119667","volume":"279","author":"BSA de Oliveira","year":"2021","unstructured":"de Oliveira, B. S. A., et al. (2021). Nanotherapeutic approach to tackle chemotherapeutic resistance of cancer stem cells. Life Sciences, 279, 119667.","journal-title":"Life Sciences"},{"issue":"6","key":"10086_CR162","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/onc.2017.348","volume":"37","author":"T Mitamura","year":"2018","unstructured":"Mitamura, T., et al. (2018). Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP). Oncogene, 37(6), 722\u2013731.","journal-title":"Oncogene"},{"issue":"11","key":"10086_CR163","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/jnci\/djj211","volume":"98","author":"S-J Kim","year":"2006","unstructured":"Kim, S.-J., et al. (2006). Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer. Journal of the National Cancer Institute, 98(11), 783\u2013793.","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10086_CR164","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3892\/mmr.2014.3058","volume":"11","author":"BX Zhao","year":"2015","unstructured":"Zhao, B. X., et al. (2015). Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975\/gefinitib-resistant with epidermal growth factor receptor T790M mutation. Molecular medicine reports, 11(4), 2767\u20132774.","journal-title":"Molecular medicine reports"},{"issue":"24","key":"10086_CR165","first-page":"6885","volume":"52","author":"C Meijer","year":"1992","unstructured":"Meijer, C., et al. (1992). Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer research, 52(24), 6885\u20136889.","journal-title":"Cancer research"},{"issue":"1","key":"10086_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-019-0560-5","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang, G., et al. (2020). Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. Journal of nanobiotechnology, 18(1), 1\u201315.","journal-title":"Journal of nanobiotechnology"},{"issue":"8","key":"10086_CR167","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.clon.2020.03.005","volume":"32","author":"M Wong-Brown","year":"2020","unstructured":"Wong-Brown, M., van der Westhuizen, A., & Bowden, N. (2020). Targeting DNA repair in ovarian cancer treatment resistance. Clinical Oncology, 32(8), 518\u2013526.","journal-title":"Clinical Oncology"},{"issue":"2","key":"10086_CR168","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4149\/neo_2015_025","volume":"62","author":"W Sun","year":"2015","unstructured":"Sun, W., et al. (2015). Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells. Neoplasma, 62(2), 199\u2013208.","journal-title":"Neoplasma"},{"issue":"10","key":"10086_CR169","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/jcm8101658","volume":"8","author":"M Teeuwssen","year":"2019","unstructured":"Teeuwssen, M., & Fodde, R. (2019). Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance. Journal of clinical medicine, 8(10), 1658.","journal-title":"Journal of clinical medicine"},{"issue":"1","key":"10086_CR170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang, L., et al. (2018). EMT-and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer. Nature communications, 9(1), 1\u201312.","journal-title":"Nature communications"},{"issue":"5","key":"10086_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-019-4007-6","volume":"25","author":"F Grisoni","year":"2019","unstructured":"Grisoni, F., et al. (2019). De novo design of anticancer peptides by ensemble artificial neural networks. Journal of Molecular Modeling, 25(5), 1\u201310.","journal-title":"Journal of Molecular Modeling"},{"key":"10086_CR172","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.compbiolchem.2019.02.004","volume":"79","author":"L Sherin","year":"2019","unstructured":"Sherin, L., Sohail, A., & Shujaat, S. (2019). Time-dependent AI-Modeling of the anticancer efficacy of synthesized gallic acid analogues. Computational biology and chemistry, 79, 137\u2013146.","journal-title":"Computational biology and chemistry"},{"issue":"13","key":"10086_CR173","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/cmdc.201800204","volume":"13","author":"F Grisoni","year":"2018","unstructured":"Grisoni, F., et al. (2018). Designing anticancer peptides by constructive machine learning. ChemMedChem, 13(13), 1300\u20131302.","journal-title":"ChemMedChem"},{"key":"10086_CR174","doi-asserted-by":"publisher","first-page":"110255","DOI":"10.1016\/j.biopha.2020.110255","volume":"128","author":"G Liang","year":"2020","unstructured":"Liang, G., et al. (2020). The emerging roles of artificial intelligence in cancer drug development and precision therapy. Biomedicine & Pharmacotherapy, 128, 110255.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10086_CR175","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jbi.2018.07.024","volume":"85","author":"G Chen","year":"2018","unstructured":"Chen, G., et al. (2018). Predict effective drug combination by deep belief network and ontology fingerprints. Journal of biomedical informatics, 85, 149\u2013154.","journal-title":"Journal of biomedical informatics"},{"key":"10086_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.19.00032","volume":"3","author":"MN Levine","year":"2019","unstructured":"Levine, M. N., et al. (2019). Learning health system for breast cancer: Pilot project experience. JCO Clinical Cancer Informatics, 3, 1\u201311.","journal-title":"JCO Clinical Cancer Informatics"},{"issue":"01","key":"10086_CR177","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-0040-1702002","volume":"29","author":"M Sma\u00efl-Tabbone","year":"2020","unstructured":"Sma\u00efl-Tabbone, M., & Rance, B. (2020). Contributions from the 2019 literature on bioinformatics and translational informatics. Yearbook of Medical Informatics, 29(01), 188\u2013192.","journal-title":"Yearbook of Medical Informatics"},{"issue":"6","key":"10086_CR178","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1378\/chest.11-0469","volume":"141","author":"X Zhu","year":"2012","unstructured":"Zhu, X., et al. (2012). An intronic polymorphism in GRP78 improves chemotherapeutic prediction in non-small cell lung cancer. Chest, 141(6), 1466\u20131472.","journal-title":"Chest"},{"issue":"7","key":"10086_CR179","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/1878-0261.12659","volume":"14","author":"C Fiorino","year":"2020","unstructured":"Fiorino, C., et al. (2020). Technology-driven research for radiotherapy innovation. Molecular oncology, 14(7), 1500\u20131513.","journal-title":"Molecular oncology"},{"issue":"3","key":"10086_CR180","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/S2589-7500(19)30058-5","volume":"1","author":"B Lou","year":"2019","unstructured":"Lou, B., et al. (2019). An image-based deep learning framework for individualising radiotherapy dose: A retrospective analysis of outcome prediction. The Lancet Digital Health, 1(3), e136\u2013e147.","journal-title":"The Lancet Digital Health"},{"key":"10086_CR181","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.compbiomed.2018.05.018","volume":"98","author":"P Meyer","year":"2018","unstructured":"Meyer, P., et al. (2018). Survey on deep learning for radiotherapy. Computers in biology and medicine, 98, 126\u2013146.","journal-title":"Computers in biology and medicine"},{"issue":"7","key":"10086_CR182","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/1744666X.2019.1623670","volume":"15","author":"P Jabbari","year":"2019","unstructured":"Jabbari, P., & Rezaei, N. (2019). Artificial intelligence and immunotherapy. Expert Review of Clinical Immunology, 15(7), 689\u2013691.","journal-title":"Expert Review of Clinical Immunology"},{"issue":"6","key":"10086_CR183","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/annonc\/mdz108","volume":"30","author":"S Trebeschi","year":"2019","unstructured":"Trebeschi, S., et al. (2019). Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Annals of Oncology, 30(6), 998\u20131004.","journal-title":"Annals of Oncology"},{"issue":"18","key":"10086_CR184","first-page":"1756","volume":"322","author":"J Abbasi","year":"2019","unstructured":"Abbasi, J. (2019). \u201cElectronic nose\u201d predicts immunotherapy response. JAMA, 322(18), 1756\u20131756.","journal-title":"JAMA"},{"key":"10086_CR185","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","volume":"124","author":"S Tan","year":"2020","unstructured":"Tan, S., Li, D., & Zhu, X. (2020). Cancer immunotherapy: Pros, cons and beyond. Biomedicine & Pharmacotherapy, 124, 109821.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10086_CR186","doi-asserted-by":"crossref","unstructured":"Tran, W. T., et al. (2019). Personalized breast cancer treatments using artificial intelligence in radiomics and pathomics. Journal of Medical Imaging and Radiation Sciences, 50(4), S32\u2013S41.","DOI":"10.1016\/j.jmir.2019.07.010"},{"key":"10086_CR187","doi-asserted-by":"crossref","unstructured":"Lamy, J.-B., et al. (2019). Explainable artificial intelligence for breast cancer: A visual case-based reasoning approach. Artificial Intelligence in Medicine, 94, 42\u201353.","DOI":"10.1016\/j.artmed.2019.01.001"},{"key":"10086_CR188","doi-asserted-by":"crossref","unstructured":"Somashekhar, S., et al. (2018). Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Annals of Oncology, 29(2), 418\u2013423.","DOI":"10.1093\/annonc\/mdx781"},{"issue":"6","key":"10086_CR189","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s42247-021-00249-8","volume":"4","author":"NK Katiyar","year":"2021","unstructured":"Katiyar, N. K., Goel, G., & Goel, S. (2021). Emergence of machine learning in the development of high entropy alloy and their prospects in advanced engineering applications. Emergent Materials, 4(6), 1635\u20131648.","journal-title":"Emergent Materials"},{"key":"10086_CR190","doi-asserted-by":"publisher","first-page":"106261","DOI":"10.1016\/j.nanoen.2021.106261","volume":"88","author":"NK Katiyar","year":"2021","unstructured":"Katiyar, N. K., et al. (2021). A perspective on the catalysis using the high entropy alloys. Nano Energy, 88, 106261.","journal-title":"Nano Energy"},{"issue":"22","key":"10086_CR191","doi-asserted-by":"publisher","first-page":"14000","DOI":"10.1021\/acscatal.1c03571","volume":"11","author":"NK Katiyar","year":"2021","unstructured":"Katiyar, N. K., et al. (2021). Electrooxidation of hydrazine utilizing high-entropy alloys: Assisting the oxygen evolution reaction at the thermodynamic voltage. ACS Catalysis, 11(22), 14000\u201314007.","journal-title":"ACS Catalysis"},{"issue":"6383","key":"10086_CR192","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1126\/science.aan5412","volume":"359","author":"Y Yao","year":"2018","unstructured":"Yao, Y., et al. (2018). Carbothermal shock synthesis of high-entropy-alloy nanoparticles. Science, 359(6383), 1489\u20131494.","journal-title":"Science"},{"issue":"7","key":"10086_CR193","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/09506608.2020.1825175","volume":"66","author":"NK Katiyar","year":"2021","unstructured":"Katiyar, N. K., Biswas, K., & Tiwary, C. (2021). Cryomilling as environmentally friendly synthesis route to prepare nanomaterials. International Materials Reviews, 66(7), 493\u2013532.","journal-title":"International Materials Reviews"},{"key":"10086_CR194","doi-asserted-by":"publisher","first-page":"100754","DOI":"10.1016\/j.pmatsci.2020.100754","volume":"120","author":"B Cantor","year":"2021","unstructured":"Cantor, B. (2021). Multicomponent high-entropy Cantor alloys. Progress in Materials Science, 120, 100754.","journal-title":"Progress in Materials Science"},{"issue":"3","key":"10086_CR195","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nnano.2008.34","volume":"3","author":"E Tasciotti","year":"2008","unstructured":"Tasciotti, E., et al. (2008). Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nature nanotechnology, 3(3), 151\u2013157.","journal-title":"Nature nanotechnology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-023-10086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-023-10086-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-023-10086-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T03:09:24Z","timestamp":1697598564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-023-10086-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":195,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10086"],"URL":"https:\/\/doi.org\/10.1007\/s10555-023-10086-2","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}